Search Articles — Sudonull

https://sudonull.com/drug-for-growing-new-teeth-trg035-trials-in-japan

Japanese startup Toregem BioPharma has started clinical trials of a drug for growing teeth. Learn how TRG035 works, risks and potential of the technology.

https://sudonull.com/ai-driven-phage-therapy-locus-biosciences-clinical-trials

Breakthrough in superbug treatment: Locus Biosciences automated phage therapy with AI and CRISPR-Cas3 moves to clinical trials. Learn about the revolution in biopharmaceuticals.

https://sudonull.com/cambridge-ai-based-vaccine-first-phase-of-trials

Cambridge scientists and DIOSynVax have created a coronavirus vaccine using AI. First phase results: safe and tolerable. Learn about the breakthrough in vaccinology.

https://sudonull.com/breakthrough-in-parkinson-s-disease-treatment-jotrol-us-trials

Critical Analysis of Jupiter Neurosciences' Phase 2a JOTROL: Bioavailability, Finances, Supplements, and Hidden Risks. Read Before Believing the Breakthrough.

https://sudonull.com/humanoid-robots-at-haneda-airport-jal-and-gmo-test

Japan launches trials of humanoid robots for ground handling at Haneda Airport. Learn how this will solve the staffing shortage and change baggage handling.

https://ymaho.com/stem-cell-kidney-growth-implant-trials-in-japan

Trials of an implant for growing kidneys from stem cells have begun in Japan. The technology could replace dialysis. Details about the breakthrough and risks — in the analysis.

https://ymaho.com/survodutide-trials-failure-or-effectiveness-in-weight-loss

Phase 3 SYNCHRONIZE-1 analysis: weight loss 13-16.6%, but 19% discontinuations due to side effects. Is it worth the risk? Read the full review.

https://ymaho.com/human-cell-rejuvenation-therapy-trials

Learn about the first clinical trial of ER-100 cell rejuvenation therapy from Life Biosciences. How epigenetic reprogramming can reverse aging. Read details.

https://ymaho.com/universal-car-t-therapy-fda-allows-trials-for-autoimmune-diseases

FDA approved clinical trials of allogeneic CAR-T cell therapy QT-019C for lupus and scleroderma. Savings up to $100 billion, no chemotherapy. Learn about the breakthrough.

https://ymaho.com/j-j-s-ottava-robot-trials-and-a-shift-in-the-surgery-market

J&J tested the OTTAVA robot with table-integrated arms for bariatric surgery. The system works in cramped operating rooms, reducing hospital costs. Learn how this will change the market.

https://ymaho.com/j-j-ottava-robot-first-clinical-trials-successfully-completed

J&J's surgical robot Ottava has passed first clinical trials in bariatric surgery. Learn about the advantages of the innovative system and its impact on the robotic surgery market.

https://ymaho.com/mrna-vaccine-moderna-against-influenza-trials-completed

mRNA vaccine Moderna against influenza outperformed traditional vaccines in a trial with 40,000 participants. Learn how this will change the market and when to expect the FDA decision.

https://ymaho.com/ema-advisory-meeting-on-clinical-trials-2026-new-rules

EMA will hold a meeting on clinical trials of innovative therapies in June 2026. New approaches to ATMP study design, RWE and CMC. Learn how the changes will affect the pharmaceutical industry.

https://ymaho.com/iscib1-dna-vaccine-for-melanoma-phase-3-approved-by-fda

FDA approved phase 3 trials of iSCIB1+ DNA vaccine against melanoma. Survival increase of 24%. Find out when the drug will be available and who it will help.

https://ymaho.com/fda-agreed-on-trial-design-for-privosegtor-in-optic-neuritis

FDA approved the design of registration trials for the neuroprotector Privosegtor for the treatment of optic neuritis. Learn how the drug can change neuro-ophthalmology and what prospects the SPA agreement opens.